Clinical Evaluation |
---|
Somatostatin receptor expression |
Type of Imaging |
PET |
Grade of Recommendation |
C/D (optional) |
Level of Evidence |
well-designed Nuclear Medicine recommendations |
Effective Dose |
17.0-23.0 µSv/MBq |
Bibliographic Reference |
Giovanella, L., Treglia, G., Iakovou, I., et al. EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma. Eur J Nucl Med Mol Imag... read moreGiovanella, L., Treglia, G., Iakovou, I., et al. EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma. Eur J Nucl Med Mol Imaging. 2020; https://doi.org/10.1007/s00259-019-04458-6. read less |
Guide to Nuclear Medicine |
Read the corresponding chapter |